NCT00935506View on ClinicalTrials.gov

Ex Vivo Human Thrombosis Chamber Study

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Cardiovascular Disease
Interventions
DRUG

Clopidogrel

Tablets, Oral, 75 mg, Once daily, 8 days

DRUG

Aspirin

Tablets, Oral, 325 mg, Once daily, 8 days

Trial Locations (1)

07753

Mds Pharma Services, Neptune City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY